Quick Answer
International Stem Cell CORP reported Stockholders Equity of -$4.06 million for fiscal year 2025.
International Stem Cell CORP Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$4.06M | -3.3% |
| 2024 | -$3.93M | +6.1% |
| 2023 | -$4.19M | +7.4% |
| 2022 | -$4.52M | +1.5% |
| 2021 | -$4.59M | -5.9% |
| 2020 | -$4.33M | -50.0% |
| 2019 | -$2.89M | -213.8% |
| 2018 | $2.54M | +22.9% |
| 2017 | $2.06M | -40.1% |
| 2016 | $3.44M | +116.1% |
| 2015 | $1.59M | +396.6% |
| 2014 | $321.0K | +107.6% |
| 2013 | -$4.22M | -140.2% |
| 2012 | -$1.76M | -148.5% |
| 2011 | $3.62M | -32.8% |
| 2010 | $5.39M | +337.4% |
| 2009 | -$2.27M | -624.2% |
| 2008 | $433.0K | +104.2% |
| 2007 | $212.0K | -95.5% |
| 2006 | $4.70M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.78M | +6.6% | +3.1% |
| June 30, 2025 | -$3.90M | +3.0% | +4.7% |
| March 31, 2025 | -$4.09M | +4.2% | -4.0% |
| December 31, 2024 | -$3.93M | +6.1% | +2.7% |
| September 30, 2024 | -$4.04M | -4.7% | -0.6% |
| June 30, 2024 | -$4.02M | -4.4% | +5.8% |
| March 31, 2024 | -$4.26M | +4.1% | -1.8% |
| December 31, 2023 | -$4.19M | +7.4% | -8.5% |
- International Stem Cell CORP showed a decrease of -3.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2006–2025 period, International Stem Cell CORP’s stockholders equity has declined by 186.4% (from $4.70 million to -$4.06 million).
- The most recent figure is from International Stem Cell CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: